Lisa Shulman
Lisa Shulman
Professor of Neurology, University of Maryland
Verified email at
Cited by
Cited by
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results
CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ...
Movement disorders: official journal of the Movement Disorder Society 23 (15…, 2008
Levodopa and the progression of Parkinson's disease
Parkinson Study Group
New England Journal of Medicine 351 (24), 2498-2508, 2004
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ...
The Lancet Neurology 18 (12), 1091-1102, 2019
Non-recognition of depression and other non-motor symptoms in Parkinson's disease
LM Shulman, RL Taback, AA Rabinstein, WJ Weiner
Parkinsonism & related disorders 8 (3), 193-197, 2002
A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study
Parkinson Study Group
Archives of neurology 59 (12), 1937-1943, 2002
Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review):[RETIRED]: Report of the Quality Standards…
JM Miyasaki, K Shannon, V Voon, B Ravina, G Kleiner-Fisman, ...
Neurology 66 (7), 996-1002, 2006
Comorbidity of the nonmotor symptoms of Parkinson's disease
LM Shulman, RL Taback, J Bean, WJ Weiner
Movement disorders: official journal of the Movement Disorder Society 16 (3…, 2001
A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study
Parkinson Study Group
Archives of Neurology 62 (2), 241-248, 2005
The clinically important difference on the unified Parkinson's disease rating scale
LM Shulman, AL Gruber-Baldini, KE Anderson, PS Fishman, SG Reich, ...
Archives of neurology 67 (1), 64-70, 2010
Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease
LM Shulman, LI Katzel, FM Ivey, JD Sorkin, K Favors, KE Anderson, ...
JAMA neurology 70 (2), 183-190, 2013
Fatigue in Parkinson's disease: a review
JH Friedman, RG Brown, C Comella, CE Garber, LB Krupp, JS Lou, ...
Movement disorders: official journal of the Movement Disorder Society 22 (3…, 2007
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
IH Richard, MP McDermott, R Kurlan, JM Lyness, PG Como, N Pearson, ...
Neurology 78 (16), 1229-1236, 2012
Movement disorders: a comprehensive survey
WJ Weiner, AE Lang
(No Title), 1989
The evolution of disability in Parkinson disease
LM Shulman, AL Gruber‐Baldini, KE Anderson, CG Vaughan, SG Reich, ...
Movement disorders 23 (6), 790-796, 2008
Parkinson's disease age at onset genome‐wide association study: defining heritability, genetic loci, and α‐synuclein mechanisms
C Blauwendraat, K Heilbron, CL Vallerga, S Bandres‐Ciga, R Von Coelln, ...
Movement Disorders 34 (6), 866-875, 2019
Gender differences in Parkinson's disease
LM Shulman
Gender medicine 4 (1), 8-18, 2007
Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
RA Hauser, LM Shulman, JM Trugman, JW Roberts, A Mori, R Ballerini, ...
Movement disorders: official journal of the Movement Disorder Society 23 (15…, 2008
The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care
RE Jensen, NE Rothrock, EM DeWitt, B Spiegel, CA Tucker, HM Crane, ...
Medical care 53 (2), 153-159, 2015
Validation of the PROMIS measures of self-efficacy for managing chronic conditions
AL Gruber-Baldini, C Velozo, S Romero, LM Shulman
Quality of Life Research 26, 1915-1924, 2017
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
Ninds Net-PD Investigators
Neurology 68 (1), 20-28, 2007
The system can't perform the operation now. Try again later.
Articles 1–20